037sek
0,5 %
Date:2024-04-26Time:17:29:00Latest report:Q4-2023List:First NorthTicker:AROC
Market Cap:86 msekEnterprise Value:35 msekNet Sales:43,0 msekEarnings:-59,3 msekEmployees:0ISIN:SE0003883990

Ratios

10-year key figure history for AroCell turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AroCell with index and moving average MA50 and MA200.

Stockprice:0,37
MA50:0,37
MA200:0,45
Price/MA200:-17,1 %
RSI (14):53,9
Price/MA50:1,7 %

Description

AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.

Biotechnology